Strategy

ASCO26: Gastrointestinal Cancers Enter the Limelight Amid Key Readout Surge

oncology · 4 min

Genstar-backed Signant Health Acquires Ametris: Implications for eCOA and Digital Outcome Measures

6 min

FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug: Implications for SCD Pipeline and BD Strategy

FDA · sickle cell disease · 4 min

FDA's Future: Insights from Former Commissioner David Kessler

FDA · 5 min

Kailera's Triple-G Drug: A Potential Game-Changer in Pharma

FDA · 5 min

FDA Shakeup: Høeg's Departure and Amgen Drug Controversy

FDA · 5 min

Physician-Led Patient Education: A Strategy to Mitigate the Gross-to-Net Squeeze

FDA · 8 min

Tenaya Therapeutics to Present TN-201 Gene Therapy Data for HCM on June 3, 2026

gene therapy · 7 min

Celcuity's Gedatolisib Trial Misses Expectations, Highlighting PIK3CA Inhibitor Challenges

breast cancer · 6 min

Eli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks

FDA · 8 min

FDA Expands ENDS Market Access: Implications for Pharma BD and Investors

FDA · 8 min

Surgeon General's Warning on Children's Screen Time: A Pharma Industry Analysis

FDA · 9 min